Patch Test Skin Irritation/Sensitization of Cetaphil Daily Facial Moisturizer SPF 50

Galderma

Status: Completed

Conditions: Skin Irritation

Treatments: Other: Cetaphil Daily Facial Moisturizer SPF 50

Study type: Interventional

Funder types: Industry

Identifiers

NCT01887860

GLI.04.SRE.US10232c

Details and patient eligibility

About

Determine if Cetaphil Daily Facial Moisturizer SPF 50 proves to be a contact sensitizer or irritant in certain individuals.

Enrollment: 100 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Not currently under a doctor's care
• Free of dermatological or systemic disorder which would interfere with the results
• Free of any acute or chronic disease
• Will complete a preliminary medical history form and are in general good health
• Can read, understand, and sign informed consent

Exclusion criteria

• Under 18 years old
• Currently under doctor's care
• Currently taking any medication
• History of acute or chronic disease
• Diagnosed with chronic skin allergies
• Pregnant or lactating

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

100 participants in 1 patient group

Cetaphil Daily Facial Moisturizer SPF50

Experimental group

Description:

All subjects receive Cetaphil Daily Facial Moisturizer SPF 50

Treatment:

Other: Cetaphil Daily Facial Moisturizer SPF 50